Puretech, Nektar Therapeutics end merger talks

by | Oct 11, 2022

Healthcare company PureTech and US-based Nektar Therapeutics have terminated merger talks only four days after they announced a potential tie up.
“These discussions were early in nature and the required announcement created the impression that discussions were more advanced than they were,” PureTech said on Tuesday.

“Given the early stage of the discussions and the potential for an extended period of uncertainty, these discussions were terminated.”

Reporting by Frank Prenesti for Sharecast.com

Related articles

AstraZeneca to buy Gracell Technologies for $1.2bn

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn. Under the terms of the deal,...

Swisscom weighing offer for Vodafone’s Italian business

Swisscom weighing offer for Vodafone’s Italian business

(Sharecast News) - Swiss telecommunications firm Swisscom has been mulling over an offer for Vodafone's Italian operations early next year, according to Bloomberg, potentially countering a rival bid from Iliad SA. The potential deal will see Vodafone's mobile service...

SSP expands into Canada, Saudi Arabia

SSP expands into Canada, Saudi Arabia

(Sharecast News) - International travel food and beverage outlet operator SSP Group on Thursday said it had expanded into Canada and Saudi Arabia as it pivots to high-growth markets. The company, which owns the Upper Crust and Ritazza brands, said it had bought...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x